Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group

P. Turton, D. El-Sharkawi, I. Lyburn, B. Sharma, P. Mahalingam, SD. Turner, F. MacNeill, L. Johnson, S. Hamilton, C. Burton, N. Mercer

. 2021 ; 192 (3) : 444-458. [pub] 20201122

Language English Country Great Britain

Document type Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21019308

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell non-Hodgkin Lymphoma (NHL) associated with breast implants. Raising awareness of the possibility of BIA-ALCL in anyone with breast implants and new breast symptoms is crucial to early diagnosis. The tumour begins on the inner aspect of the peri-implant capsule causing an effusion, or less commonly a tissue mass to form within the capsule, which may spread locally or to more distant sites in the body. Diagnosis is usually made by cytological, immunohistochemical and immunophenotypic evaluation of the aspirated peri-implant fluid: pleomorphic lymphocytes are characteristically anaplastic lymphoma kinase (ALK)-negative and strongly positive for CD30. BIA-ALCL is indolent in most patients but can progress rapidly. Surgical removal of the implant with the intact surrounding capsule (total en-bloc capsulectomy) is usually curative. Late diagnosis may require more radical surgery and systemic therapies and although these are usually successful, poor outcomes and deaths have been reported. By adopting a structured approach, as suggested in these guidelines, early diagnosis and successful treatment will minimise the need for systemic treatments, reduce morbidity and the risk of poor outcomes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019308
003      
CZ-PrNML
005      
20210830100858.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bjh.17194 $2 doi
035    __
$a (PubMed)33222158
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Turton, Philip $u St James's Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
245    10
$a UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group / $c P. Turton, D. El-Sharkawi, I. Lyburn, B. Sharma, P. Mahalingam, SD. Turner, F. MacNeill, L. Johnson, S. Hamilton, C. Burton, N. Mercer
520    9_
$a Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell non-Hodgkin Lymphoma (NHL) associated with breast implants. Raising awareness of the possibility of BIA-ALCL in anyone with breast implants and new breast symptoms is crucial to early diagnosis. The tumour begins on the inner aspect of the peri-implant capsule causing an effusion, or less commonly a tissue mass to form within the capsule, which may spread locally or to more distant sites in the body. Diagnosis is usually made by cytological, immunohistochemical and immunophenotypic evaluation of the aspirated peri-implant fluid: pleomorphic lymphocytes are characteristically anaplastic lymphoma kinase (ALK)-negative and strongly positive for CD30. BIA-ALCL is indolent in most patients but can progress rapidly. Surgical removal of the implant with the intact surrounding capsule (total en-bloc capsulectomy) is usually curative. Late diagnosis may require more radical surgery and systemic therapies and although these are usually successful, poor outcomes and deaths have been reported. By adopting a structured approach, as suggested in these guidelines, early diagnosis and successful treatment will minimise the need for systemic treatments, reduce morbidity and the risk of poor outcomes.
650    _2
$a prsní implantáty $x škodlivé účinky $7 D018427
650    _2
$a management nemoci $7 D019468
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a anaplastický velkobuněčný lymfom $x diagnóza $x etiologie $x patologie $x terapie $7 D017728
650    _2
$a zákroky plastické chirurgie $x škodlivé účinky $7 D019651
650    _2
$a plastická chirurgie $x škodlivé účinky $7 D013518
651    _2
$a Spojené království $7 D006113
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a El-Sharkawi, Dima $u Royal Marsden NHS Foundation Trust, London, UK
700    1_
$a Lyburn, Iain $u Cobalt Medical Charity, Cheltenham, UK $u Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
700    1_
$a Sharma, Bhupinder $u Royal Marsden NHS Foundation Trust, London, UK
700    1_
$a Mahalingam, Preethika $u Royal Marsden NHS Foundation Trust, London, UK
700    1_
$a Turner, Suzanne D $u Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK $u CEITEC, Masaryk University, Brno, Czech Republic
700    1_
$a MacNeill, Fiona $u Royal Marsden NHS Foundation Trust, London, UK
700    1_
$a Johnson, Laura $u Barts Health NHS Trust, London, UK
700    1_
$a Hamilton, Stephen $u Royal Free Hospital, London, UK
700    1_
$a Burton, Cathy $u St James's Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
700    1_
$a Mercer, Nigel $u Bristol Plastic Surgery, Bristol, UK
773    0_
$w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 192, č. 3 (2021), s. 444-458
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33222158 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100858 $b ABA008
999    __
$a ok $b bmc $g 1690190 $s 1139754
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 192 $c 3 $d 444-458 $e 20201122 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
LZP    __
$a Pubmed-20210728
Back

Find record

Citation metrics

Archiving options